We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Thermo Fisher Scientific Signs New Agreements to Expand Oncomine Dx Target Test

Product News   May 02, 2018

 
Thermo Fisher Scientific Signs New Agreements to Expand Oncomine Dx Target Test

Credit: Thermo Fisher Scientific

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Owlstone Medical Announces Key Study Results on Use of Breath Biopsy for Improved Detection of Liver Disease Including NASH and NAFLD

Product News

Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the results of a patient study that successfully demonstrates the use of exhaled limonene as a breath biomarker to measure liver function and stage liver disease.

READ MORE

ERS Genomics Announces Agreement With Applied StemCell To Commercialize CRISPR Gene Editing Solutions

Product News

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property announced it has signed an agreement with Applied StemCell, Inc., a leading provider of stem cell, animal model, antibody discovery services and reagents to commercialize CRISPR gene editing.

READ MORE

UK Medtech Firm Launches App for COVID-19 Test To Help Control Pandemic

Product News

A UK medtech firm has developed a companion app for a COVID-19 test that could soon help world governments and health agencies manage and control the coronavirus pandemic.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE